Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -2025/26 group results

May 14 (Reuters)- 
          Reprocell Incorporated 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT   
              Mar 31, 2026    Mar 31, 2025    Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           2.23            2.98            2.63                  
               (-25.0 pct)     (+22.7 pct)    (+17.7 pct)               
  Operating   loss 860 mln    loss 130 mln    loss 630 mln              
  Recurring   loss 581 mln       45 mln       loss 458 mln              
                               (+12.1 pct)                              
  Net
  Net         loss 591 mln       103 mln      loss 458 mln              
  EPS         loss 6.25 yen     1.11 yen     loss 4.82 yen              
  Ann Div          NIL             NIL            NIL                   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div          NIL             NIL            NIL                   
  
  NOTE - Reprocell Incorporated.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news